Studies investigating the role of [TIMP-2]*[IGFBP7] in the prediction of AKI and defining cut-off values in cardiovascular patient populations are rare and currently restricted to adult and pediatric open cardiac surgery. This evidence concerns the gene TIMP2 and acute kidney injury.